Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is taken once a week, every week, on the same chosen day. That single weekly injection is the complete dosing schedule for the duration of treatment — there is no loading phase requiring more frequent injections, and no maintenance phase where you drop to monthly. What does change, under your prescriber's guidance, is the strength of each weekly dose as your body adjusts. These are prescription-only medicines; a clinician assesses whether Wegovy is appropriate for you before any prescription is issued, and the titration plan is set by them, not self-directed. The full Wegovy overview covers the broader picture if you'd like the context alongside the schedule detail.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear fairly often is whether you can speed things up by injecting Wegovy more than once a week. It's an understandable thought, if one injection works, would two work better? The evidence and the licence both say no. Semaglutide has a half-life of around one week, which is precisely why it was designed as a once-weekly medicine, and if you're wondering how many times a week you can take semaglutide, the answer is once, because a second injection in the same seven-day period wouldn't double the effect and would stack doses in a way the clinical programme never tested and the prescribing guidance explicitly does not support.
That misconception is worth gently setting aside, because the actual schedule is more thoughtful than it might first appear. The five-rung titration (starting at 0.25 mg and working towards 2.4 mg) exists to let your digestive system adapt gradually. Nausea, the most common early side effect, is significantly more likely if you jump straight to a higher strength. The four weeks at each level aren't a slow-down; they're a clinical design choice. The step-by-step guide to taking Wegovy walks through the practical side of each injection if that's useful.
The STEP 1 trial, published in the New England Journal of Medicine, used this once-weekly 2.4 mg schedule over 68 weeks and found an average body-weight reduction of around 15%, a figure achieved through consistent weekly dosing at the right strength, not by compressing the schedule.
You pick a day of the week that suits your routine (many people choose a weekend morning) and that day becomes your Wegovy day for as long as treatment continues. The injection goes into the skin of your abdomen, thigh or upper arm; you rotate the site each week to reduce the chance of local irritation. The pen stays in the fridge until the day you use it.
As the months pass, your prescriber moves you up through the dose levels: 0.25 mg for the first four weeks, then 0.5 mg, then 1.0 mg, then 1.7 mg, before reaching the 2.4 mg maintenance dose. Each step is one pen, one injection per week. The newer 7.2 mg maintenance dose (approved by the MHRA in April 2026 and available in a dedicated single-dose pen) follows the same principle: still one injection per week, just at the higher strength for adults with obesity where the prescriber determines it is appropriate.
Life doesn't always cooperate with a fixed schedule. If you need to move your injection day, there's a minimum gap rule to follow, the guidance on spacing Wegovy doses covers this properly. For anything more than a minor shift, the Patient Information Leaflet and your prescriber are the right places to check, not a forum post.
It happens. You forget, you're travelling, the pen isn't where you thought it was. The rule is straightforward in principle: if fewer than five days have passed since your missed dose, take it as soon as you remember and then resume your usual day. If it's been five days or more, skip that week entirely and carry on with your next scheduled injection. Doubling up to compensate is not advised.
The detail on late Wegovy doses goes further on the timing specifics, and the general FAQs have common follow-up questions. If you've missed several doses in a row or you're unsure what to do in your particular situation, speak directly to your prescriber. At nume, aftercare runs seven days a week for exactly these moments, a question doesn't have to wait until Monday.
Consistency matters because semaglutide works by maintaining a steady level in your system. Irregular dosing doesn't ruin treatment, but regular weekly injections give it the best conditions to work.
Wegovy's once-weekly schedule means you're looking at roughly four pens per 28-day period at whatever strength you're on. The Wegovy cost page breaks down what private treatment actually involves in terms of price, because the headline figure from one provider rarely tells the full story, consultation fees, prescription charges and aftercare support vary considerably across services.
On the NHS, Wegovy is recommended by NICE (TA875) for use within specialist weight management services, for a maximum of two years, with specific BMI and comorbidity criteria. Waiting times for those services can be long. Private treatment through a regulated online pharmacy is the route for people who don't meet the current NHS thresholds or don't want to wait, subject to clinical suitability assessed by a real prescriber, not an automated form.
Our clinical team reviews every consultation personally. If Wegovy looks like it could be right for you, a free consultation is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.